Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study points to new gene therapy tool in preventing epileptic seizures

25.07.2003


A new study by gene therapy scientists at the University of North Carolina at Chapel Hill may lead to an effective long-term treatment for preventing seizures associated with a common form of epilepsy. The study appears this week in the Internet edition of the journal Nature Medicine and will appear in the Aug. 1 print edition of the journal. The research provides an important foundation for the development of new gene therapies to treat focal seizure disorders, the authors said.



As the name indicates, focal (or partial) seizures involve an electrical storm affecting only a part of the brain. Such seizures may remain localized or spread to other parts of the cerebral cortex. The temporal lobes, one on each side of the head just above the ears, are the brain sites of one of the most common forms of epilepsy involving focal seizures.

"Epilepsy afflicts approximately 1 percent of the U.S. population. A large proportion of epileptic adults have temporal lobe epilepsy, which is often very difficult to treat, and for about 30 percent of those individuals the only treatment option is surgery," said study co-author Dr. Thomas J. McCown, associate professor of psychiatry in UNC’s School of Medicine and a member of the UNC Gene Therapy Center. That option is surgical resection, or removal of abnormal brain tissue at the site linked to the seizures. However, despite resection, only 50 percent to 60 percent of temporal lobe epilepsy patients improve following the surgery.


In the new research, McCown and his Gene Therapy Center colleagues Rebecca Haberman, a post-doctoral fellow, and Dr. R. Jude Samulski, center director and professor of pharmacology, used a novel strategy to make laboratory rats less sensitive to experimentally induced focal seizures.

The researchers used an altered adeno-associated virus, or AAV, to deliver into the animals’ brain cells a coded sequence for the production of galanin, a neuroactive peptide known to suppress seizure activity.

In earlier studies, McCown and his team learned there would be no attenuation of seizure activity if galanin was produced within neurons and wasn’t secreted from the cells. In addition, brain cells would die following induced seizures. Moreover, these cells were in a brain area intimately involved in temporal lobe epilepsy, McCown said.

In the new research, the cargo delivered via AAV included coded instructions for galanin and a secretory sequence that caused the galanin to be non-specifically secreted from the cell. In one experiment, sensitivity to focal seizure was reduced significantly. In another model seizure experiment, the AAV "construct" was delivered to only one side of the brain. Cell death after seizure induction occurred only in the untreated area.

"The treated side looked normal," McCown said. "This suggests that we can secrete an active peptide in a brain structure that’s closely tied to temporal lobe seizures."

Gene expression following delivery the AAV construct can be turned off by the antibiotic doxycycline, which McCown said was an important feature of the research. "Whether it be via an antimicrobial compound or an analog, this is an absolutely crucial component to human gene therapy. You have to be able to turn gene expression off."

In terms of focal seizure control through gene therapy, the new study brings researchers a step closer to resolving a major issue: how to influence only a specific area of the brain. "In the case of seizures, the area is much more restrictive than that of a single-gene disorder where you need to hit most of the cells in a large proportion of the brain," McCown said.

Further laboratory studies with this new gene therapy platform may prove promising for treatment of temporal lobe epilepsy patients who are slated for surgery, McCown said. "You could put in this AAV vector prior to surgery and then see what effect it has on the tissue to be removed. If it controls seizure activity, you might have to reconsider resection."

Contact: Mc Cown at +1-919-966-3081, thomas_mccown@med.unc.edu

Leslie Lang | EurekAlert!
Further information:
http://www.med.unc.edu

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Rare find from the deep sea

20.02.2018 | Life Sciences

In living color: Brightly-colored bacteria could be used to 'grow' paints and coatings

20.02.2018 | Life Sciences

Observing and controlling ultrafast processes with attosecond resolution

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>